No Data
No Data
Eli Lilly Alzheimer's Therapy Approved in China
Hoshino RR, Japan Pharmacists ETC (additional) Rating
Downgrade - Bearish Code Stock Name Securities Company Previous Changed ------------------------------------------------------- <3697> SHIFT JPM "Over W" "Neutral" <8306> Mitsubishi UFJ JPM "Over W" "Neutral" <8316> Sumitomo Mitsui JPM "Over W" "Neutral" Target Price Change Code Stock Name Securities Company Previous Changed --------------
Eisai's EA Pharma, Newron In Agreement For Evenamide In Japan And Other Asian Territories
Newron Pharmaceuticals Signs Schizophrenia Drug License Deal in Japan, Asia
Stocks that moved the day before part 1: Perseus, Symphony Technology, Japan Micronics, ETC.
Stock name <code> Closing price on the 12th ⇒ Change from the previous day Cell source <4880> 1052 +30 Collaborated with Docomo, agreed to consider collaboration with Japan Post. Digi HD <3676> 830 +362 Financial Estimates for the period ending March 2025 have been revised downward for revenue but upward for net profit estimates. P-Ban <3559> 382 +17 Announced a forecast for the dividend for the period ending March 2025, which was initially undecided, to be 10 yen, an increase of 2 yen from the previous period. Silver Life <9262> 724 -45 First quarter operating profit decreased by 29.4%. Perseus.
Jefferies Adjusts Eisai's Price Target to 4,200 Yen From 5,500 Yen, Keeps at Hold